Denver, Colorado - This morning’s tape is defined by strategic repositioning across healthcare, AI infrastructure, and digital platforms. From cross-border biologics ambitions to enterprise AI alliances and improving profitability profiles, companies are signaling where capital and execution are heading in 2026.
Totaligent Expands Biologics and APAC Ambitions with Binding JV
Totaligent (OTCID:TGNT) announced the execution of a binding Letter of Intent to form a joint venture with GloMed Solutions, a Japanese medical aesthetics and biologics distributor generating approximately $10 million in annual revenue and $1 million in free cash flow.
The agreement integrates Totaligent’s Aetherium Medical platform into GloMed’s infrastructure and grants Totaligent a binding one-year call option to acquire 100% of GloMed following completion of a PCAOB-compliant audit and customary approvals. The JV is structured without initial cash consideration and includes a three-member board featuring Totaligent CEO Edward DeFeudis, GloMed CEO Don Heath, and Aetherium’s Ivan Klarich.
Strategically, the move positions Totaligent at the intersection of biologics commercialization and medical tourism across Asia-Pacific. With global biologics projected to approach $650 billion by 2030 and medical tourism forecasts ranging from $56 billion in 2026 to more than $250 billion by 2034, the company is attempting to evolve from marketing-data services into infrastructure-enabled healthcare commercialization. Execution of definitive agreements and due diligence remain key milestones.
Healthcare Triangle Taps 25 Million-User Ecosystem in Malaysia
Healthcare Triangle, Inc. (NASDAQ:HCTI) announced that its subsidiary QuantumNexis Malaysia entered a strategic partnership with TNG Digital, operator of Malaysia’s leading digital financial services platform with over 25 million verified users.
The integration embeds QuantumNexis’s digital mental health platform directly into the TNG eWallet ecosystem, offering in-app discovery, single sign-on, and frictionless payments. The model aims to address regional shortages in mental health professionals by scaling digital-first assessments and structured support pathways.
For Healthcare Triangle, the partnership signals a shift toward population-scale deployment in Southeast Asia, where high digital adoption and regulatory support create fertile ground for embedded healthcare services.
AMD and Nutanix Deepen Enterprise AI Push with Strategic Investment
Advanced Micro Devices (NASDAQ:AMD) and Nutanix (NASDAQ:NTNX) unveiled a multi-year strategic partnership to develop an open, full-stack AI infrastructure platform for enterprise and service providers.
AMD will invest $150 million in Nutanix common stock at $36.26 per share and fund up to $100 million in joint engineering and go-to-market initiatives. The companies plan to integrate AMD EPYC CPUs, AMD Instinct GPUs, and ROCm software into the Nutanix Cloud and Kubernetes platforms, targeting scalable inference and agentic AI deployments.
The first jointly developed platform is expected to reach market beginning in late 2026. The agreement reinforces AMD’s positioning in open AI ecosystems as inference workloads increasingly dominate enterprise deployments.
Butterfly Network Delivers Record Revenue and Positive Operating Cash Flow
Butterfly Network (NYSE:BFLY) reported fourth-quarter revenue of $31.5 million, up 41% year-over-year, marking a quarterly record. The company generated positive operating cash flow for the first time in its history and ended the year with $150.5 million in cash.
Full-year 2026 guidance calls for revenue of $117–$121 million, representing projected growth of 20%–24%, with an adjusted EBITDA loss between $21 million and $25 million.
Butterfly’s Q4 included $6.8 million in revenue tied to its co-development partnership with Midjourney, part of a broader five-year agreement disclosed in late 2025. The company continues transitioning from a medical device manufacturer into a semiconductor-driven imaging platform centered on its Ultrasound-on-Chip™ architecture.
Ibotta Shows Redeemer Growth Despite Revenue Contraction
Ibotta (NYSE:IBTA) reported fourth-quarter revenue of $88.5 million, down 10% year-over-year, while delivering adjusted EBITDA of $13.7 million. Full-year revenue declined 7% to $342.4 million, but the company generated $62.9 million in adjusted EBITDA and $95.3 million in operating cash flow.
Total redeemers grew 19% year-over-year in Q4, driven in part by expanded availability of offers to DoorDash customers and growth among third-party publishers. The company also repurchased 6.9 million shares during 2025 for $233.8 million.
Ibotta’s outlook for Q1 2026 calls for revenue of $78–$82 million and adjusted EBITDA of $6–$8 million, signaling continued near-term pressure even as platform engagement metrics improve.
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact [email protected] to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing TGNT market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://go.247marketnews.com/tgnt-disclosure/ for further TGNT and 247marketnews.com disclosure information.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.